Skip to main content
WBF What is
brain fog?
Support WBF Take quiz

Test guide Blood test

Candida Antibody Test: IgG, IgA, and IgM

This panel shows whether your blood has IgG, IgA, or IgM antibodies to Candida. A positive result doesn't show where Candida is growing. Match it with your symptoms, immune health, and a test from the body site that may be infected.

Blood antibodies The panel measures three types of Candida albicans antibodies in blood. What positive means Normal contact with Candida can make antibodies even when there's no active infection. Test the affected area Mouth, vaginal, skin, swallowing, and hospital symptoms need different examinations and samples.
01

What does a Candida antibody panel show?

Candida lives on and inside many healthy people, so a positive antibody result doesn't always mean an active infection. Before treatment, match the result with the place you have symptoms, your immune health, and a test that can check that body site.

What it measures

It finds antibodies in the blood

The panel reports IgG, IgA, and IgM antibodies. It doesn't measure Candida yeast in the mouth, gut, vagina, skin, blood, or organs.

Common mistake

A positive result doesn't prove an active infection

The test shows an immune response, not where yeast is growing or whether it needs treatment.

What changes the next step

The place with symptoms guides the next test

Mouth, skin, vaginal, or swallowing symptoms need an exam and a sample from that area. Fever in a very ill person or someone with a weak immune system needs prompt care.

Use a test from the place with symptoms

A mouth, skin, vaginal, blood, or organ infection needs its own exam or sample. This antibody panel cannot confirm all of them.

Save this test

Save your Candida IgG, IgA, and IgM results together

Keep all three results with the lab cutoffs, where you have symptoms, your health risks, and the next test or plan.

02

What decides which Candida illness is likely and which sample is right?

Labs don't list separate antibody cutoffs by age or sex. Age, pregnancy, diabetes, medicines, immune health, hospital care, and the place with symptoms help decide which test you need.

Children, babies, and teenagers

Online explanations written for adults don't apply to a child. Babies under one month have a higher risk of oral thrush, and very premature or very-low-birth-weight infants can be at risk for invasive disease in hospital. Those questions need pediatric examination, site-specific testing, or hospital care, not a home reading of this panel.

Sex and symptom location

Labs don't publish separate male and female antibody cutoffs. The relevant difference is often the body site. Vaginal symptoms need an examination and a sample tested for yeast; mouth, skin, swallowing, or hospital symptoms need a different path.

Pregnancy and postpartum

Vaginal yeast infections are common during pregnancy, but this blood test doesn't diagnose the cause of vaginal symptoms. Use a pregnancy-aware clinician and a sample from the symptomatic area before treatment because medicine choices and other causes of discharge, pain, or itching need care.

Immune suppression and serious illness

Cancer treatment, neutropenia, transplant, broad-spectrum antibiotics, central lines, dialysis, abdominal surgery, intensive care, and immune medicines change the risk. A negative antibody panel can't safely rule out invasive infection. A new fever in a high-risk person needs prompt medical assessment and the invasive-infection pathway.

Older adults

Oral health, blood sugar control, inhalers, recent antibiotics, hospital stays, operations, dialysis, and immune health can change Candida risk. New confusion, weakness, poor intake, painful swallowing, or a rapid decline deserves direct assessment rather than waiting for an antibody repeat.

03

How to get ready for a Candida antibody blood test

Before the appointment, confirm the exact order. A Candida albicans IgG, IgA, and IgM panel is an antibody test. It's different from a blood or fungal culture, beta-D-glucan test, allergy test, stool test, or vaginal swab.

Ask whether the laboratory requires any special preparation. ARUP Laboratories' current listing doesn't state a fasting requirement. It uses a serum separator tube and asks the laboratory to separate serum from cells as soon as possible or within two hours.

Say exactly where the symptoms are. Mouth patches, pain with swallowing, vaginal itching or discharge, a skin rash, and fever during a hospital stay lead to different examinations and samples. Brain fog, fatigue, bloating, or sugar cravings alone don't identify Candida infection.

Bring a medicine list and mention anything that raises infection risk. Include recent antibiotics or steroids, cancer or immune treatment, diabetes, pregnancy, dentures, dry mouth, hospital care, surgery, dialysis, or a central line. Bring any past culture or swab result.

Keep taking prescribed antibiotics, steroids, immune medicines, diabetes medicines, and inhalers before the blood test. Do not start an antifungal, boric acid, restrictive diet, cleanse, or supplement to make the antibody result look different.

01

Confirm what was measured

Save the laboratory, order code, method, IgG, IgA, and IgM values, units or index format, and the cutoff printed beside each antibody. Different laboratories report this panel differently.

02

Match the test to the body site

Use a sample from the affected area when the question is about the mouth, skin, or vagina. A possible infection in the blood or an organ needs the correct culture or other standard test.

03

Ask what would confirm infection

Before treatment, ask what symptom, examination finding, local sample, culture, or hospital risk factor would make Candida the likely cause rather than background antibody exposure.

04

How do you read Candida IgG, IgA, and IgM?

Use the cutoff printed by your lab for each antibody. Add where you have symptoms, recent medicines, immune health, pregnancy, diabetes, hospital care, and any sample or culture result.

All antibodies negative

Your lab reports all three antibodies as negative

The test didn't find a clear Candida antibody response. A local infection may still need an exam or a sample from that body site. A very ill person with a weak immune system needs direct medical care.

Equivocal or hard to compare

One or more antibodies are equivocal (unclear), close to the cutoff, or hard to compare because the lab or method changed

Check the cutoff on your report, why you had the test, where you have symptoms, and your immune health. Ask if the lab wants another sample after a set amount of time.

One or more antibodies positive

Your lab reports one or more antibodies as positive

The test found Candida antibodies. They may come from a current infection, an old infection, or normal Candida living in the body. An exam or a sample from the place with symptoms can help tell the difference.

Antibodies don't confirm an active infection

The test can't always tell normal Candida in the body from a deep infection. It may also be negative in a person with a weak immune system who has a serious infection.

See research details

Laboratory detection does not establish local infection, and background antibodies or isotype limits can mislead. Use guideline-supported tests and account for immune suppression before linking a result to brain fog.

SourceA positive panel doesn't prove active infection ContextLabcorp states that antibodies can be detected in uninfected people exposed to commensal yeasts and that the assay cannot distinguish mucosal colonization from deep infection.

Ask which specific infection they're considering and what separate finding would confirm it.

SourceThe three antibodies can't simply tell past from active infection ContextARUP reports each positive component as antibody detected that may indicate current or past infection. It also notes that low IgM can sometimes last for more than 12 months and that a significant change between two samples is stronger evidence than one sample.

Do not label IgA or IgM as active mucosal overgrowth from one result, and do not label IgG as harmless past exposure without the full clinical context.

SourcePositive results are common without active infection ContextPrince et al. found positive results among people without apparent systemic candidiasis, including 24 to 32 percent for IgG, 2 to 14 percent for IgM, and 15 to 36 percent for IgA across three serum panels.

Treat a positive result as something that needs a clinical match, not as proof that Candida explains the symptoms.

SourceThe generic panel is not the guideline mannan pair ContextThe 2025 global guideline moderately recommends combined serum mannan antigen and anti-mannan antibody as an additional tool for suspected candidemia or invasive candidiasis. IDSA also describes that paired assay as the best-studied antibody approach, with variable performance and an unclear role in management.

Ask whether guidelines actually support this panel as an add-on test, and whether the person is in the high-risk clinical group the research covered.

SourceTest the body site that has symptoms ContextCDC describes vaginal microscopy or culture, mouth or throat examination and sampling, endoscopy for esophageal disease, and culture of blood or an infected body site for invasive disease.

If symptoms point to one body site, use the exam and sample for that site. The blood antibody panel can't answer every Candida question.

SourceImmune suppression can blunt the result ContextLabcorp warns that a negative result doesn't rule out deep candidiasis in immunocompromised people. CDC says invasive candidiasis mainly affects people who are critically ill, hospitalized, immunocompromised, or exposed to specific medical risks.

Do not use a negative panel to delay urgent assessment when fever, chills, severe illness, a central line, recent abdominal surgery, neutropenia, transplant, or intensive-care risk is present.

SourceThis panel doesn't prove a link to brain fog ContextSeverance et al. measured Candida albicans IgG in schizophrenia and bipolar cohorts and reported sex-specific associations with cognition. The authors called for further investigation.

The study doesn't show that Candida antibodies diagnose a fungal cause of brain fog or that lowering an antibody changes cognition.

05

What can you do before treatment?

Write down where and when symptoms happen. Simple care may lower the risk of a local yeast infection, but do not try to treat an antibody number.

Keep a short body-site and timing record

Note mouth changes, pain with swallowing, vaginal symptoms, skin rash, fever, and any recent hospital stay. Add antibiotic or steroid timing, periods or pregnancy, blood sugar problems, and when brain fog changes. A clear location and timeline is more useful than a long list of vague Candida symptoms.

Use simple prevention that matches the site

CDC suggests good mouth care. Rinse your mouth or brush your teeth after using an inhaled steroid. Wear breathable clothing and cotton underwear, and keep the genital area clean and dry. These steps may reduce local risk, but they do not treat invasive disease or prove why a blood antibody is positive.

Use antibiotics and steroids only as directed

Antibiotics and corticosteroids can increase candidiasis risk. Take them as prescribed and ask about mouth rinsing, symptom monitoring, or other prevention that fits the medicine. Do not stop a needed medicine on your own.

Ask for the sample that matches recurring symptoms

Persistent vaginal symptoms, recurring mouth patches, painful swallowing, or a skin rash can have other causes. A direct examination and site-specific sample can stop repeated self-treatment from hiding the real diagnosis.

When you need medical care

Do not start antifungals, boric acid, a restrictive Candida diet, fasting, cleanses, probiotics, homeopathy, essential oils, or supplements from this antibody panel alone. Get urgent help for fever or chills after recent hospital care or when your immune system is weak. Also get help for severe confusion, fainting, trouble breathing, chest pain, trouble swallowing fluids, or symptoms that worsen within hours.

06

Keep the full results with the reason you had the test

Keep these together

  • Laboratory, order code, test method, collection date, report date, sample type, and any fasting or other preparation instructions.
  • IgG, IgA, and IgM values, units or index format, and the negative, equivocal, or positive cutoff printed for each.
  • The symptom site and timing: mouth, swallowing, vagina, skin, fever, recent hospital care, or vague symptoms like brain fog and fatigue.
  • Health risks: medicine use, cancer or immune treatment, diabetes, pregnancy, oral health, an operation or hospital stay, dialysis, an intravenous device, and intensive care.
  • Any mouth examination, vaginal sample, skin sample, blood culture, sterile-site sample, beta-D-glucan, mannan or anti-mannan test, and clinician interpretation.
  • The decision made: no action, site-specific testing, repeat paired antibody sample, infection review, or a different brain-fog workup.

Question for the visit

“Does this result match a specific Candida illness, and what site-specific examination, sample, culture, or hospital risk would confirm it before treatment?”
07

Sources for Candida Antibody Panel (IgG, IgA, IgM)

01
Current lab source: Labcorp Candida Antibodies, IgA, IgG, IgM

ELISA method, serum specimen, research-use limitation, colonization-versus-infection limit, immune-suppression limit, result format, and rejection criteria

02
Current lab source: ARUP Candida albicans IgA, IgG, and IgM

Limited-utility ordering note, serum collection, processing, EV cutoffs, paired-specimen interpretation, persistent IgM limit, and laboratory-developed-test status

03
Academic lab source: Michigan Medicine MLabs Candida Antibody Panel

Healthy-person antibodies, blunted immune responses, fungal-culture preference, specimen, and current send-out context

04
CDC: Testing and Diagnosis for Candidiasis

Site-specific examination, microscopy, culture, endoscopy, and invasive-disease testing

05
CDC: Clinical Overview of Invasive Candidiasis

Commensal biology, hospital and immune risk groups, blood-culture pathway, and urgent clinical context

06
CDC: Risk Factors for Candidiasis

Age, pregnancy, diabetes, medicines, immune suppression, hospital, device, and surgery context

07
CDC: Preventing Candidiasis

Oral health, inhaled-steroid mouth care, breathable clothing, local dryness, and medicine-use prevention advice

08
CDC: Vulvovaginal Candidiasis Guidance

Vaginal symptom limits, microscopy and culture, colonization without symptoms, pregnancy context, and unsupported home remedies

09
Cornely et al., Lancet Infectious Diseases, 2025, PMID 39956121

Current global guideline scope for mucocutaneous and invasive candidiasis and adjunctive diagnostic tools

10
Open-access 2025 global candidiasis guideline

Current recommendation text for mannan and anti-mannan adjunctive testing and clinical-context requirements

11
IDSA Clinical Practice Guideline for Candidiasis

Culture standards, antibody-test limits, mannan and anti-mannan evidence, and high-risk invasive-disease context

12
Prince et al., Journal of Clinical Laboratory Analysis, 2008, PMID 18623122

IgG, IgA, and IgM ELISA performance and seroreactivity among people without apparent systemic candidiasis

13
Severance et al., NPJ Schizophrenia, 2016, PMID 27336058

Sex-specific cohort associations between Candida IgG and cognition, not diagnostic or treatment validation

See each claim's sources

interpretation

One Candida IgG, IgA, or IgM result cannot be assigned a simple past-versus-active-infection meaning; current laboratory guidance allows current or past infection for positive components and notes that low IgM can persist.